Tapewire

Nasdaq · USD

DXCM

DEXCOM INC

Export transactions ↓
Tapewire entity
3114
SEC CIK
0001093557
Parsed reports
937

Last 12 months

Inside the activity.

2 purchase rows · 30 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202523
Dec 202500
Jan 202600
Feb 202601
Mar 202601
Apr 202601
May 202603
Jun 202605
Jul 202604
Aug 202607
Sep 202605
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 01, 2021 Filed Oct 5, 2021 22:28 UTC SaleCommon Stock 181 $544.39 $98,535.13
Disclosure

SEC source: 0001093557-21-000235 · edgardoc.xml · nonDerivative · entry 5

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 13,649

F1 · shares: On June 15, 2021, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F4 · price: This transaction was executed in multiple trades at prices ranging from $544.07 to $544.82. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee.

Read SEC document
October 01, 2021 Filed Oct 5, 2021 22:28 UTC SaleCommon Stock 126 $543.15 $68,436.61
Disclosure

SEC source: 0001093557-21-000235 · edgardoc.xml · nonDerivative · entry 4

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 13,830

F1 · shares: On June 15, 2021, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F3 · price: This transaction was executed in multiple trades at prices ranging from $542.79 to $543.64. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee.

Read SEC document
October 01, 2021 Filed Oct 5, 2021 22:28 UTC SaleCommon Stock 88 $540.93 $47,601.84
Disclosure

SEC source: 0001093557-21-000235 · edgardoc.xml · nonDerivative · entry 3

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 13,956

F1 · shares: On June 15, 2021, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee.

Read SEC document
October 01, 2021 Filed Oct 5, 2021 22:28 UTC SaleCommon Stock 6 $539.10 $3,234.60
Disclosure

SEC source: 0001093557-21-000235 · edgardoc.xml · nonDerivative · entry 2

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 14,044

F1 · shares: On June 15, 2021, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee.

Read SEC document
October 01, 2021 Filed Oct 5, 2021 22:28 UTC SaleCommon Stock 47 $538.02 $25,286.94
Disclosure

SEC source: 0001093557-21-000235 · edgardoc.xml · nonDerivative · entry 1

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 14,050

F1 · shares: On June 15, 2021, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee.

Read SEC document
September 23, 2021 Filed Sep 25, 2021 00:01 UTC
Pacelli Steven RobertManaging Dir., Dexcom Ventures
SaleCommon Stock 250 $576.58 $144,144.00
Disclosure

SEC source: 0001093557-21-000233 · edgardoc.xml · nonDerivative · entry 8

Pacelli Steven Robert · CIK 0001359098 · Managing Dir., Dexcom Ventures

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,079

F1 · shares: On June 14, 2021, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F10 · price: This transaction was executed in multiple trades at prices ranging from $576.480 to $576.635. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 13,673 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 23, 2021 Filed Sep 25, 2021 00:01 UTC
Pacelli Steven RobertManaging Dir., Dexcom Ventures
SaleCommon Stock 1,312 $575.74 $755,375.60
Disclosure

SEC source: 0001093557-21-000233 · edgardoc.xml · nonDerivative · entry 7

Pacelli Steven Robert · CIK 0001359098 · Managing Dir., Dexcom Ventures

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,329

F1 · shares: On June 14, 2021, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F9 · price: This transaction was executed in multiple trades at prices ranging from $575.28 to $576.16. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 13,673 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 23, 2021 Filed Sep 25, 2021 00:01 UTC
Pacelli Steven RobertManaging Dir., Dexcom Ventures
SaleCommon Stock 554 $574.90 $318,493.49
Disclosure

SEC source: 0001093557-21-000233 · edgardoc.xml · nonDerivative · entry 6

Pacelli Steven Robert · CIK 0001359098 · Managing Dir., Dexcom Ventures

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,641

F1 · shares: On June 14, 2021, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F8 · price: This transaction was executed in multiple trades at prices ranging from $574.28 to $575.26. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 13,673 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 23, 2021 Filed Sep 25, 2021 00:01 UTC
Pacelli Steven RobertManaging Dir., Dexcom Ventures
SaleCommon Stock 1,744 $573.60 $1,000,359.10
Disclosure

SEC source: 0001093557-21-000233 · edgardoc.xml · nonDerivative · entry 5

Pacelli Steven Robert · CIK 0001359098 · Managing Dir., Dexcom Ventures

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,195

F1 · shares: On June 14, 2021, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F7 · price: This transaction was executed in multiple trades at prices ranging from $573.18 to $574.17. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 13,673 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 23, 2021 Filed Sep 25, 2021 00:01 UTC
Pacelli Steven RobertManaging Dir., Dexcom Ventures
SaleCommon Stock 983 $572.60 $562,863.54
Disclosure

SEC source: 0001093557-21-000233 · edgardoc.xml · nonDerivative · entry 4

Pacelli Steven Robert · CIK 0001359098 · Managing Dir., Dexcom Ventures

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,939

F1 · shares: On June 14, 2021, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F6 · price: This transaction was executed in multiple trades at prices ranging from $572.150 to $573.055. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 13,673 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 23, 2021 Filed Sep 25, 2021 00:01 UTC
Pacelli Steven RobertManaging Dir., Dexcom Ventures
SaleCommon Stock 1,142 $571.50 $652,655.51
Disclosure

SEC source: 0001093557-21-000233 · edgardoc.xml · nonDerivative · entry 3

Pacelli Steven Robert · CIK 0001359098 · Managing Dir., Dexcom Ventures

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,922

F1 · shares: On June 14, 2021, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F5 · price: This transaction was executed in multiple trades at prices ranging from $571.03 to $572.00. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 13,673 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 23, 2021 Filed Sep 25, 2021 00:01 UTC
Pacelli Steven RobertManaging Dir., Dexcom Ventures
SaleCommon Stock 438 $570.42 $249,846.06
Disclosure

SEC source: 0001093557-21-000233 · edgardoc.xml · nonDerivative · entry 2

Pacelli Steven Robert · CIK 0001359098 · Managing Dir., Dexcom Ventures

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,064

F1 · shares: On June 14, 2021, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F4 · price: This transaction was executed in multiple trades at prices ranging from $570.01 to $570.85. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 13,673 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 23, 2021 Filed Sep 25, 2021 00:01 UTC
Pacelli Steven RobertManaging Dir., Dexcom Ventures
SaleCommon Stock 320 $569.63 $182,282.21
Disclosure

SEC source: 0001093557-21-000233 · edgardoc.xml · nonDerivative · entry 1

Pacelli Steven Robert · CIK 0001359098 · Managing Dir., Dexcom Ventures

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,502

F1 · shares: On June 14, 2021, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $569.01 to $569.69. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 13,673 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 15, 2021 Filed Sep 16, 2021 23:01 UTC
SAYER KEVIN RDirector · Chairman, CEO & President
SaleCommon Stock 613 $544.07 $333,512.64
Disclosure

SEC source: 0001093557-21-000231 · edgardoc.xml · nonDerivative · entry 8

SAYER KEVIN R · CIK 0001286858 · Director · Chairman, CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,705

F1 · shares: On July 31, 2020, Mr. Sayer adopted a 10b5-1 Plan, which was amended effective June 15, 2021. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F10 · price: This transaction was executed in multiple trades at prices ranging from $543.74 to $544.50. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 36,385 unvested restricted stock units, 13,445 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,968 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 5,972 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 15, 2021 Filed Sep 16, 2021 23:01 UTC
SAYER KEVIN RDirector · Chairman, CEO & President
SaleCommon Stock 932 $543.18 $506,241.71
Disclosure

SEC source: 0001093557-21-000231 · edgardoc.xml · nonDerivative · entry 7

SAYER KEVIN R · CIK 0001286858 · Director · Chairman, CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,318

F1 · shares: On July 31, 2020, Mr. Sayer adopted a 10b5-1 Plan, which was amended effective June 15, 2021. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F9 · price: This transaction was executed in multiple trades at prices ranging from $542.69 to $543.66. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 36,385 unvested restricted stock units, 13,445 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,968 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 5,972 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 15, 2021 Filed Sep 16, 2021 23:01 UTC
SAYER KEVIN RDirector · Chairman, CEO & President
SaleCommon Stock 1,252 $541.88 $678,437.89
Disclosure

SEC source: 0001093557-21-000231 · edgardoc.xml · nonDerivative · entry 6

SAYER KEVIN R · CIK 0001286858 · Director · Chairman, CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,250

F1 · shares: On July 31, 2020, Mr. Sayer adopted a 10b5-1 Plan, which was amended effective June 15, 2021. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F8 · price: This transaction was executed in multiple trades at prices ranging from $541.48 to $542.44. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 36,385 unvested restricted stock units, 13,445 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,968 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 5,972 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 15, 2021 Filed Sep 16, 2021 23:01 UTC
SAYER KEVIN RDirector · Chairman, CEO & President
SaleCommon Stock 640 $540.92 $346,187.20
Disclosure

SEC source: 0001093557-21-000231 · edgardoc.xml · nonDerivative · entry 5

SAYER KEVIN R · CIK 0001286858 · Director · Chairman, CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,502

F1 · shares: On July 31, 2020, Mr. Sayer adopted a 10b5-1 Plan, which was amended effective June 15, 2021. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F7 · price: This transaction was executed in multiple trades at prices ranging from $540.44 to $541.33. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 36,385 unvested restricted stock units, 13,445 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,968 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 5,972 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 15, 2021 Filed Sep 16, 2021 23:01 UTC
SAYER KEVIN RDirector · Chairman, CEO & President
SaleCommon Stock 700 $539.59 $377,711.32
Disclosure

SEC source: 0001093557-21-000231 · edgardoc.xml · nonDerivative · entry 4

SAYER KEVIN R · CIK 0001286858 · Director · Chairman, CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,142

F1 · shares: On July 31, 2020, Mr. Sayer adopted a 10b5-1 Plan, which was amended effective June 15, 2021. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F6 · price: This transaction was executed in multiple trades at prices ranging from $539.310 to $540.135. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 36,385 unvested restricted stock units, 13,445 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,968 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 5,972 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 15, 2021 Filed Sep 16, 2021 23:01 UTC
SAYER KEVIN RDirector · Chairman, CEO & President
SaleCommon Stock 413 $538.63 $222,455.97
Disclosure

SEC source: 0001093557-21-000231 · edgardoc.xml · nonDerivative · entry 3

SAYER KEVIN R · CIK 0001286858 · Director · Chairman, CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,842

F1 · shares: On July 31, 2020, Mr. Sayer adopted a 10b5-1 Plan, which was amended effective June 15, 2021. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F5 · price: This transaction was executed in multiple trades at prices ranging from $538.20 to $539.16. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 36,385 unvested restricted stock units, 13,445 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,968 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 5,972 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 15, 2021 Filed Sep 16, 2021 23:01 UTC
SAYER KEVIN RDirector · Chairman, CEO & President
SaleCommon Stock 1,050 $537.45 $564,320.51
Disclosure

SEC source: 0001093557-21-000231 · edgardoc.xml · nonDerivative · entry 2

SAYER KEVIN R · CIK 0001286858 · Director · Chairman, CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,255

F1 · shares: On July 31, 2020, Mr. Sayer adopted a 10b5-1 Plan, which was amended effective June 15, 2021. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F4 · price: This transaction was executed in multiple trades at prices ranging from $537.13 to $537.91. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 36,385 unvested restricted stock units, 13,445 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,968 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 5,972 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 15, 2021 Filed Sep 16, 2021 23:01 UTC
SAYER KEVIN RDirector · Chairman, CEO & President
SaleCommon Stock 400 $536.49 $214,594.52
Disclosure

SEC source: 0001093557-21-000231 · edgardoc.xml · nonDerivative · entry 1

SAYER KEVIN R · CIK 0001286858 · Director · Chairman, CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,305

F1 · shares: On July 31, 2020, Mr. Sayer adopted a 10b5-1 Plan, which was amended effective June 15, 2021. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $536.13 to $536.92. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 36,385 unvested restricted stock units, 13,445 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,968 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 5,972 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 13, 2021 Filed Sep 15, 2021 20:14 UTC
Patterson ChadEVP, Global Marketing
SaleCommon Stock 156 $541.47 $84,469.32
Disclosure

SEC source: 0001093557-21-000229 · edgardoc.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · EVP, Global Marketing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,744

F1 · shares: On June 14, 2021, Mr. Patterson adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Patterson. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · balance_after: Included in this number are 9,603 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,394 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 575 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 10, 2021 Filed Sep 10, 2021 20:15 UTC
Blackford Quentin S.Chief Operating Officer
SaleCommon Stock 1,519 $558.33 $848,103.27
Disclosure

SEC source: 0001093557-21-000202 · edgardoc.xml · nonDerivative · entry 14

Blackford Quentin S. · CIK 0001612451 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,280

F3 · shares: On February 17, 2021 Mr. Blackford adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Blackford. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · balance_after: Included in this number are 19,047 unvested restricted stock units, 7,491 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 8,484 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 3,072 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 10, 2021 Filed Sep 14, 2021 00:19 UTC
Selvaraj Shelly RamasamySVP Information Technology
SaleCommon Stock 681 $558.33 $380,222.73
Disclosure

SEC source: 0001093557-21-000224 · edgardoc.xml · nonDerivative · entry 11

Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,014

F4 · shares: On May 30, 2019, Mr. Selvaraj adopted a 10b5-1 Plan which was amended on May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F3 · balance_after: Included in this number are 8,106 unvested restricted stock units, 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,655 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,378 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 10, 2021 Filed Sep 14, 2021 00:00 UTC
Flynn Paul REVP, Global Revenue
SaleCommon Stock 626 $558.33 $349,514.58
Disclosure

SEC source: 0001093557-21-000213 · edgardoc.xml · nonDerivative · entry 3

Flynn Paul R · CIK 0001850141 · EVP, Global Revenue

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,928

F3 · shares: On December 11, 2020, Mr. Flynn adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Flynn. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · balance_after: Included in this number are 10,928 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,916 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,378 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 09, 2021 Filed Sep 10, 2021 20:15 UTC
Blackford Quentin S.Chief Operating Officer
SaleCommon Stock 200 $551.28 $110,255.00
Disclosure

SEC source: 0001093557-21-000202 · edgardoc.xml · nonDerivative · entry 13

Blackford Quentin S. · CIK 0001612451 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,799

F3 · shares: On February 17, 2021 Mr. Blackford adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Blackford. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F10 · price: This transaction was executed in multiple trades at prices ranging from $551.15 to $551.42. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F2 · balance_after: Included in this number are 19,047 unvested restricted stock units, 7,491 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 8,484 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 3,072 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 09, 2021 Filed Sep 10, 2021 20:15 UTC
Blackford Quentin S.Chief Operating Officer
SaleCommon Stock 2,200 $550.51 $1,211,130.80
Disclosure

SEC source: 0001093557-21-000202 · edgardoc.xml · nonDerivative · entry 12

Blackford Quentin S. · CIK 0001612451 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,999

F3 · shares: On February 17, 2021 Mr. Blackford adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Blackford. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F9 · price: This transaction was executed in multiple trades at prices ranging from $549.95 to $550.84. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F2 · balance_after: Included in this number are 19,047 unvested restricted stock units, 7,491 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 8,484 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 3,072 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 09, 2021 Filed Sep 10, 2021 20:15 UTC
Blackford Quentin S.Chief Operating Officer
SaleCommon Stock 2,394 $549.45 $1,315,371.33
Disclosure

SEC source: 0001093557-21-000202 · edgardoc.xml · nonDerivative · entry 11

Blackford Quentin S. · CIK 0001612451 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,199

F3 · shares: On February 17, 2021 Mr. Blackford adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Blackford. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F8 · price: This transaction was executed in multiple trades at prices ranging from $548.93 to $549.91. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F2 · balance_after: Included in this number are 19,047 unvested restricted stock units, 7,491 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 8,484 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 3,072 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 09, 2021 Filed Sep 10, 2021 20:15 UTC
Blackford Quentin S.Chief Operating Officer
SaleCommon Stock 1,200 $548.40 $658,075.20
Disclosure

SEC source: 0001093557-21-000202 · edgardoc.xml · nonDerivative · entry 10

Blackford Quentin S. · CIK 0001612451 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,593

F3 · shares: On February 17, 2021 Mr. Blackford adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Blackford. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F7 · price: This transaction was executed in multiple trades at prices ranging from $547.885 to $548.790. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F2 · balance_after: Included in this number are 19,047 unvested restricted stock units, 7,491 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 8,484 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 3,072 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 09, 2021 Filed Sep 10, 2021 20:15 UTC
Blackford Quentin S.Chief Operating Officer
SaleCommon Stock 900 $547.28 $492,549.30
Disclosure

SEC source: 0001093557-21-000202 · edgardoc.xml · nonDerivative · entry 9

Blackford Quentin S. · CIK 0001612451 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,793

F3 · shares: On February 17, 2021 Mr. Blackford adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Blackford. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F6 · price: This transaction was executed in multiple trades at prices ranging from $546.75 to $547.67. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F2 · balance_after: Included in this number are 19,047 unvested restricted stock units, 7,491 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 8,484 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 3,072 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 09, 2021 Filed Sep 10, 2021 20:15 UTC
Blackford Quentin S.Chief Operating Officer
SaleCommon Stock 100 $545.10 $54,510.00
Disclosure

SEC source: 0001093557-21-000202 · edgardoc.xml · nonDerivative · entry 8

Blackford Quentin S. · CIK 0001612451 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,693

F3 · shares: On February 17, 2021 Mr. Blackford adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Blackford. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · balance_after: Included in this number are 19,047 unvested restricted stock units, 7,491 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 8,484 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 3,072 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 09, 2021 Filed Sep 10, 2021 20:15 UTC
Blackford Quentin S.Chief Operating Officer
SaleCommon Stock 100 $543.66 $54,366.00
Disclosure

SEC source: 0001093557-21-000202 · edgardoc.xml · nonDerivative · entry 7

Blackford Quentin S. · CIK 0001612451 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,793

F3 · shares: On February 17, 2021 Mr. Blackford adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Blackford. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · balance_after: Included in this number are 19,047 unvested restricted stock units, 7,491 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 8,484 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 3,072 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 09, 2021 Filed Sep 10, 2021 20:15 UTC
Blackford Quentin S.Chief Operating Officer
SaleCommon Stock 300 $542.83 $162,849.90
Disclosure

SEC source: 0001093557-21-000202 · edgardoc.xml · nonDerivative · entry 6

Blackford Quentin S. · CIK 0001612451 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,893

F3 · shares: On February 17, 2021 Mr. Blackford adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Blackford. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F5 · price: This transaction was executed in multiple trades at prices ranging from $542.55 to $543.40. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F2 · balance_after: Included in this number are 19,047 unvested restricted stock units, 7,491 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 8,484 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 3,072 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 09, 2021 Filed Sep 10, 2021 20:15 UTC
Blackford Quentin S.Chief Operating Officer
SaleCommon Stock 515 $541.45 $278,846.24
Disclosure

SEC source: 0001093557-21-000202 · edgardoc.xml · nonDerivative · entry 5

Blackford Quentin S. · CIK 0001612451 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,193

F3 · shares: On February 17, 2021 Mr. Blackford adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Blackford. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F4 · price: This transaction was executed in multiple trades at prices ranging from $541.36 to $541.79. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F2 · balance_after: Included in this number are 19,047 unvested restricted stock units, 7,491 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 8,484 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 3,072 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 09, 2021 Filed Sep 10, 2021 20:15 UTC
Blackford Quentin S.Chief Operating Officer
SaleCommon Stock 19 $542.03 $10,298.53
Disclosure

SEC source: 0001093557-21-000202 · edgardoc.xml · nonDerivative · entry 4

Blackford Quentin S. · CIK 0001612451 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,708

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: Included in this number are 19,047 unvested restricted stock units, 7,491 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 8,484 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 3,072 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 09, 2021 Filed Sep 10, 2021 20:15 UTC
Blackford Quentin S.Chief Operating Officer
SaleCommon Stock 1,534 $541.36 $830,446.24
Disclosure

SEC source: 0001093557-21-000202 · edgardoc.xml · nonDerivative · entry 3

Blackford Quentin S. · CIK 0001612451 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,727

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: Included in this number are 19,047 unvested restricted stock units, 7,491 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 8,484 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 3,072 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 09, 2021 Filed Sep 14, 2021 00:01 UTC
Sylvain Jereme MEVP, Chief Financial Officer
SaleCommon Stock 5 $541.76 $2,708.80
Disclosure

SEC source: 0001093557-21-000220 · edgardoc.xml · nonDerivative · entry 2

Sylvain Jereme M · CIK 0001681267 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,526

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: Included in this number are 11,033 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,654 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 804 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 1,274 of which were granted on November 8, 2018 and shall vest through November 8, 2021.

Read SEC document
September 09, 2021 Filed Sep 14, 2021 00:01 UTC
Sylvain Jereme MEVP, Chief Financial Officer
SaleCommon Stock 402 $541.36 $217,626.72
Disclosure

SEC source: 0001093557-21-000220 · edgardoc.xml · nonDerivative · entry 1

Sylvain Jereme M · CIK 0001681267 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,531

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: Included in this number are 11,033 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,654 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 804 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 1,274 of which were granted on November 8, 2018 and shall vest through November 8, 2021.

Read SEC document
September 09, 2021 Filed Sep 14, 2021 00:19 UTC
Selvaraj Shelly RamasamySVP Information Technology
SaleCommon Stock 241 $550.63 $132,702.58
Disclosure

SEC source: 0001093557-21-000224 · edgardoc.xml · nonDerivative · entry 10

Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,695

F4 · shares: On May 30, 2019, Mr. Selvaraj adopted a 10b5-1 Plan which was amended on May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F11 · price: This transaction was executed in multiple trades at prices ranging from $550.47 to $551.38. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 8,106 unvested restricted stock units, 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,655 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,378 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 09, 2021 Filed Sep 14, 2021 00:19 UTC
Selvaraj Shelly RamasamySVP Information Technology
SaleCommon Stock 423 $549.86 $232,592.22
Disclosure

SEC source: 0001093557-21-000224 · edgardoc.xml · nonDerivative · entry 9

Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,936

F4 · shares: On May 30, 2019, Mr. Selvaraj adopted a 10b5-1 Plan which was amended on May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F10 · price: This transaction was executed in multiple trades at prices ranging from $549.38 to $550.28. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 8,106 unvested restricted stock units, 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,655 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,378 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 09, 2021 Filed Sep 14, 2021 00:19 UTC
Selvaraj Shelly RamasamySVP Information Technology
SaleCommon Stock 341 $548.85 $187,158.63
Disclosure

SEC source: 0001093557-21-000224 · edgardoc.xml · nonDerivative · entry 8

Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,359

F4 · shares: On May 30, 2019, Mr. Selvaraj adopted a 10b5-1 Plan which was amended on May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F9 · price: This transaction was executed in multiple trades at prices ranging from $548.30 to $549.28. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 8,106 unvested restricted stock units, 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,655 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,378 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 09, 2021 Filed Sep 14, 2021 00:19 UTC
Selvaraj Shelly RamasamySVP Information Technology
SaleCommon Stock 280 $547.71 $153,358.41
Disclosure

SEC source: 0001093557-21-000224 · edgardoc.xml · nonDerivative · entry 7

Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,700

F4 · shares: On May 30, 2019, Mr. Selvaraj adopted a 10b5-1 Plan which was amended on May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F8 · price: This transaction was executed in multiple trades at prices ranging from $547.29 to $548.16. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 8,106 unvested restricted stock units, 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,655 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,378 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 09, 2021 Filed Sep 14, 2021 00:19 UTC
Selvaraj Shelly RamasamySVP Information Technology
SaleCommon Stock 80 $546.43 $43,714.00
Disclosure

SEC source: 0001093557-21-000224 · edgardoc.xml · nonDerivative · entry 6

Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,980

F4 · shares: On May 30, 2019, Mr. Selvaraj adopted a 10b5-1 Plan which was amended on May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F7 · price: This transaction was executed in multiple trades at prices ranging from $546.10 to $546.75. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 8,106 unvested restricted stock units, 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,655 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,378 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 09, 2021 Filed Sep 14, 2021 00:19 UTC
Selvaraj Shelly RamasamySVP Information Technology
SaleCommon Stock 60 $542.39 $32,543.40
Disclosure

SEC source: 0001093557-21-000224 · edgardoc.xml · nonDerivative · entry 5

Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,060

F4 · shares: On May 30, 2019, Mr. Selvaraj adopted a 10b5-1 Plan which was amended on May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F6 · price: This transaction was executed in multiple trades at prices ranging from $542.07 to $542.55. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 8,106 unvested restricted stock units, 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,655 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,378 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 09, 2021 Filed Sep 14, 2021 00:19 UTC
Selvaraj Shelly RamasamySVP Information Technology
SaleCommon Stock 101 $541.08 $54,648.96
Disclosure

SEC source: 0001093557-21-000224 · edgardoc.xml · nonDerivative · entry 4

Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,120

F4 · shares: On May 30, 2019, Mr. Selvaraj adopted a 10b5-1 Plan which was amended on May 11, 2020. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F5 · price: This transaction was executed in multiple trades at prices ranging from $540.65 to $541.36. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 8,106 unvested restricted stock units, 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,655 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,378 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 09, 2021 Filed Sep 14, 2021 00:19 UTC
Selvaraj Shelly RamasamySVP Information Technology
SaleCommon Stock 8 $542.94 $4,343.52
Disclosure

SEC source: 0001093557-21-000224 · edgardoc.xml · nonDerivative · entry 3

Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,221

F2 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F3 · balance_after: Included in this number are 8,106 unvested restricted stock units, 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,655 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,378 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 09, 2021 Filed Sep 14, 2021 00:19 UTC
Selvaraj Shelly RamasamySVP Information Technology
SaleCommon Stock 689 $541.36 $372,997.04
Disclosure

SEC source: 0001093557-21-000224 · edgardoc.xml · nonDerivative · entry 2

Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,229

F2 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F3 · balance_after: Included in this number are 8,106 unvested restricted stock units, 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,655 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,378 of which were granted on March 8, 2019 and shall vest through March 8, 2022.

Read SEC document
September 09, 2021 Filed Sep 14, 2021 00:19 UTC SaleCommon Stock 50 $551.45 $27,572.50
Disclosure

SEC source: 0001093557-21-000223 · edgardoc.xml · nonDerivative · entry 12

Balo Andrew K · CIK 0001323190 · *

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 7,553

F5 · shares: On March 5, 2021, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F3 · ownership.nature: Shares are held by the Balo Family Trust U/A/D 4/6/2006, with respect to which the reporting person is a trustee.

Read SEC document
September 09, 2021 Filed Sep 14, 2021 00:19 UTC SaleCommon Stock 1,200 $550.36 $660,433.44
Disclosure

SEC source: 0001093557-21-000223 · edgardoc.xml · nonDerivative · entry 11

Balo Andrew K · CIK 0001323190 · *

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 7,603

F5 · shares: On March 5, 2021, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F11 · price: This transaction was executed in multiple trades at prices ranging from $549.99 to $550.73. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · ownership.nature: Shares are held by the Balo Family Trust U/A/D 4/6/2006, with respect to which the reporting person is a trustee.

Read SEC document
September 09, 2021 Filed Sep 14, 2021 00:19 UTC SaleCommon Stock 1,261 $549.43 $692,836.90
Disclosure

SEC source: 0001093557-21-000223 · edgardoc.xml · nonDerivative · entry 10

Balo Andrew K · CIK 0001323190 · *

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 8,803

F5 · shares: On March 5, 2021, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F10 · price: This transaction was executed in multiple trades at prices ranging from $548.93 to $549.92. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · ownership.nature: Shares are held by the Balo Family Trust U/A/D 4/6/2006, with respect to which the reporting person is a trustee.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.